Much current attention has been focused on angiotensin I converting enzyme (ACE) inhibitors as antihypertensive drugs since the development of therapeutically effective inhibitors such as captopril'1).
In the course of our screening program from microbial origin, we found that an actinomycete strain identified as Actinomadura spiculosospora nov. sp. K-4 produced a novel ACE inhibitor designated K-42).
In this communication, we report the production, isolation, physico-chemical and biological
properties of K-4. The taxonomic studies of the producing organism and structure elucidation of K-43) will be published in separated papers.
Materials and Methods

Materials
Carboxypeptidase A (bovine pancreas) was obtained from Sigma. Carboxypeptidase B (porcine pancreas) was from Boehringer-Mannheim and a-chymotrypsin (bovine pancreas) and trypsin (bovine pancreas) were purchased from Worthington Biochem. Hippuryl-L-histidyl-L-leucine (HHL) and hippuryl-L-arginine were the products of Protein Research Foundation, Osaka. Hippuryl-L-phenylalanine was the product of Sigma. Benzoyl-L-tyrosine ethyl ester and p-tosyl-L-arginine methyl ester hydrochloride were from Nakarai Chemical Ltd. Leupeptin, antipain and chymostatin were purchased from Protein Research Foundation, Osaka.
Rabbit Lung Acetone Powder Extract
Rabbit lung acetone powder was extracted with 10 volumes of 50 mM sodium borate buffer, pH 8.3, by stirring gently overnight at 4°C and centrifuged for 40 minutes at 40,000 x g. The supernatant which contained about 200 munits/ml of ACE activity was used for ACE assay.
Assays for Enzyme Inhibitory Activities Inhibiton against ACE: Assay of ACE was based on the method of CUSHMAN and CHEUNG4) by use of HHL as a substrate. The assay mixture (total volume, 300 d) consisted of 3 mm HHL, 0.3 M NaCl, 50 mM sodium borate buffer, pH 8.3, and 50 pl of rabbit lung acetone powder extract (ca. 10 munits) with or without inhibitors. The reaction was started by the addition of 50 p1 of rabbit lung acetone powder extract and then the assay mixture was incubated for 30 minutes at 37°C. The reaction was terminated by the addition of 250 ip1 of 1 N HCl. The hippuric acid formed was extracted from the acidified solution into 1.5 ml of ethyl acetate. After centrifugation (3,000 rpm, 15 minutes), 1 ml of the upper layer was transferred into a glass tube and evaporated at 120°C for 30 minutes in vacuo. The hippuric acid was redissolved in 3.0 ml of 50 mM sodium borate buffer, pH 8.3, and quantified from its absorbance at 228 nm. Hippuric acid formation increased linearly with time at least for 30 minutes.
Inhibition against Carboxypeptidase A, Carboxypeptidase B, Chymotrypsin and Trypsin: The assay mixtures (total volume of each assay tube, 3 ml) were as follows: 1 mm hippuryl-L-phenylalanine, 25 mM Tris-HCl containing 0.5 M NaCl (pH 7.5) and 0.06 units/ml enzyme for carboxypeptidase A5); 1 mm hippuryl-L-arginine, 25 mm Tris-HCl containing 0.1 M NaCl (pH 7.65) and 0.2 units/ml enzyme for carboxypeptidase B6) ; 0.5 mm benzoyl-L-tyrosine ethyl ester, 40 mm Tris-HCl containing 50 mM CaCl, (pH 7.8) and 6 munits/ml enzyme for chymotrypsin7) ; 1 mM _p-tosyl-L-arginine methyl ester hydrochloride, 40 mm Tris-HCl containing 10 mm CaCl2 (pH 8.1) and 0.15 units/ml enzyme for trypsin7), with or without inhibitors. The reaction velocity was determined by measuring the increase in absorbancy at 254, 254, 256, 247 nm for carboxypeptidases A, B, chymotrypsin and trypsin, respectively, with a Hitachi Model 200-20 Spectrophotometer.
The assay was carried out at room temperature.
One unit of enzyme activity was defined as the amount of enzyme which catalyzed cleavage of I pmol of a substrate per minute at 37°C for ACE and at room temperature for other enzymes. Production A 30-liter jar fermentor containing 18 liters of the fermentation medium was inoculated with 0.9 liter of the seed culture grown in 2-liter Erlenmeyer flasks containing 300 ml of the seed medium on a rotary shaker at 28°C for 2 ~ 3 days.
The seed medium consisted of glucose 1 %, soluble starch I %, beef extract 0.3 %, yeast extract 0.5 %, Bacto-tryptone 0.5 %, and CaCO3 0.2 % (pH 7.2 before sterilization).
The fermentation medium consisted of soluble starch 4 %, soy bean meal 3 %, corn steep liquor 0.5 %, K2HPO4 0.05 %, MgSO4.7H2O 0.05 %, KCl 0.03 %, and CaCO3 0.3 % (pH 7.8 before sterilization). Fermentation was carried out at 30°C with aeration (18 liters/minute) and agitation (300 rpm).
Measurement of the Pressor Response to Angiotensin I in Rats
Male Sprague-Dawley strain rats weighing about 350 g were anesthetized with urethane (1.5 g/ kg, ip). Blood pressure was measured with a pressure transducer (Nihon Kohden, MPU-0.5A) through polyethylene cannula placed in the carotid artery and recorded on a polygraph (Nihon Kohden RM-600). Angiotensins I and II were injected into the jugular vein. K-4 was injected from the tail vein. Growth was expressed as packed cell volume that was determined by centrifugation at 3,000 rpm for 15 minutes. Table 1 . The UV spectrum of K-4 is shown in Fig. 3 and the IR spectrum is shown in Fig. 4 . Acid hydrolysis of K-4 (6 N HCl, 110°C, 20 hours) gave phenylalanine and an unidentified control experiments. Table 2 shows the results. The concentration of each inhibitor in each assay was 33.3 pg/ml. Leupeptin and antipain, chymostatin, and ~-phenylpropionic acid strongly inhibited trypsin, chymotrypsin, and carboxypeptidase A, respectively, but at the same conditions, K-4 did not inhibit the proteases. The results indicated that K-4 was a specific inhibitor of ACE. After ACE and K-4 were pre-incubated at 37°C for 0~ 60 minutes, the substrate solution was added to the mixture and then the enzyme reaction proceeded at 37°C for 15 minutes. Fig. 5 indicated that the inhibition of K-4 against ACE was not affected by the preincubation time. The reaction mixture (2 ml) containing ACE 10.6 munits, K-4 100 pg and 50 mm sodium borate buffer, pH 8.3, was incubated at 37°C for 75 minutes. This solution had no ACE inhibitory activity. The solution was dialyzed overnight at 4°C against 50 mm sodium borate buffer, pH 8.3; ACE inhibitory activity of this solution was completely recovered. These results indicated that K-4 was not decomposed by ACE at least for 60 minutes at 37°C and that the inhibition of K-4 against ACE is not progressive and irreversible, but reversible.
As shown in Fig. 6 , K-4 was a non-competitive inhibitor against ACE by use of HHL as a substrate whereas captopril was a competitive inhibitor as reported previously10). The Ki value of K-4 was 0.18 / M. The linearity of Dixon plots suggested that one molecule of K-4 inhibited one molecule of ACE.
K-4 contained the phosphonic acid-containing residue, (R)-1-amino-2-(4-hydroxyphenyl)ethylphosphonic acid, as the C-terminal residue as described above. Since fosfomycinll), FR-3156412), FR-9009812), FR-90013713), and alaphosphin14), etc. are known to be phosphonic acid-containing antimicrobial agents, antimicrobial activity of K-4 against Escherichia coli and ACE inhibitory activity of these phsophonic acid-containing antimicrobial agents were tested. As shown in Table 3 , K-4 had no antimicrobial activity and the phosphonic acid-containing antimicrobial agents had no ACE inhibitory activities.
Inhibition of the Pressor Response to Angiotensin I in Rats by K-4 Fig. 7a shows the pressor response to angiotensins I and II (each, 0.3 IIg/kg, iv) in rats. The pressor response to angiotensin I (0.3 pg/kg, iv) was completely inhibited by the previous administration of K-4 (1 mg/kg, iv), but the pressor response to angiotensin 11 (0.3 pg/kg, iv) was not (Fig. 7b) .
The results indicated that inhibition of the pressor response to angiotensin I in rats by K-4 was due to inhibition of ACE. The pressor response to angiotensin I (0.3 pg/kg, iv) was inhibited in a dose dependent manner over 0.1 mg/kg of K-4 (iv injection, 5 minutes before injection of angiotensin I). The IC,, of K-4 was 0.21 mg/kg (Fig. 8 ).
Discussion
We found that A. spiculosospora nov. sp. K-4 produced K-4, a novel inhibitor of ACE2). Later, KIDO et al.15) reported 15B1 from an Actinomadura strain, which was identical with K-4. However, it is possible that the phosphonic acid moiety of K-4 binds to Zn2+ at the active site of ACE. K-4 was a reversible inhibitor of ACE and inhibited ACE non-competitively by use of HHL as a substrate, whereas captopril was a competitive inhibitor. The hypothetical model of the binding site on ACE of captopril and HHL was proposed by CUSHMAN et a1. 1, 10) . The binding site of K-4, even though it is a part of the binding site of angiotensin I, is possibly different from that of captopril and HHL.
